TAVI: current and future perspectives for adjunctive antithrombotic therapy

Chairpersons: G. DANGAS, R. WELSH


To understand TAVI: patient population characteristics, approved devices and expected clinical outcomes
To evaluate current and future antithrombotic therapy options around TAVI
To learn about future perspectives and upcoming studies


Session objectives

G. Dangas

TAVI: a paradigm shift in the treatment of aortic stenosis - past, present and future

M.B. Leon

Future perspective and upcoming studies

P. Vranckx

Solved and unsolved issues of antithrombotic therapy after TAVI

U. Landmesser

Valve leaflet motion abnormality

R. Makkar

Session evaluation and key learnings

R. Welsh


More from Bayer

Visit website